海克卡因盐酸盐 | 532-76-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 海克卡因盐酸盐
• 中文别名: 盐酸海克卡因；盐酸己卡因
• 英文名称: hexylcaine hydrochloride
• 英文别名: hexylcaine monohydrochloride；benzoic acid-(β-cyclohexylamino-isopropyl ester); hydrochloride；Benzoesaeure-(β-cyclohexylamino-isopropylester); Hydrochlorid；hexylcaine HCl；2-Benzoyloxypropyl(cyclohexyl)azanium;chloride
• CAS: 532-76-3
• 化学式: C₁₆H₂₃NO₂*ClH
• 分子量: 297.825
• InChiKey: MTFCPNHRBINLRQ-UHFFFAOYSA-N

物化性质

• 熔点：
  177-178.5°
• 溶解度：
  可溶于DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  3.58
• 重原子数：
  20
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  38.3
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2922199090

反应信息

• 作为产物：
  描述：

  1-环己基氨基-2-丙醇 、 苯甲酰氯 在 盐酸 作用下， 生成 海克卡因盐酸盐
  参考文献：
  名称：

  US2486374

  摘要：

  公开号：

文献信息

• Nitric Oxide Releasing Prodrugs of Therapeutic Agents
  申请人：SATYAM Apparao

  公开号：US20110263526A1

  公开（公告）日：2011-10-27

  The present invention relates to nitric oxide releasing prodrugs of known drugs or therapeutic agents which are represented herein as compounds of formula (I) wherein the drugs or therapeutic agents contain one or more functional groups independently selected from a carboxylic acid, an amino, a hydroxyl and a sulfhydryl group. The invention also relates to processes for the preparation of the nitric oxide releasing prodrugs (the compounds of formula (I)), to pharmaceutical compositions containing them and to methods of using the prodrugs.

  本发明涉及已知药物或治疗剂的一氧化氮释放前药，其在此处表示为式(I)的化合物，其中药物或治疗剂包含一个或多个功能基团，独立地选自羧酸、氨基、羟基和巯基。该发明还涉及制备一氧化氮释放前药（式(I)的化合物）的方法，含有它们的药物组合物以及使用这些前药的方法。
• Compositions and methods for treatment of premature ejaculation
  申请人：NexMed (Holdings) Inc.

  公开号：US20040241245A1

  公开（公告）日：2004-12-02

  Compositions and methods for the treatment of premature ejaculation are provided wherein a composition comprising a topical anesthetic, a shear-thinning polymeric thickener, a lipophilic component that is selected from the group consisting of an aliphatic C 1 to C 8 alcohol, an aliphatic C 8 to C 30 ester, a liquid polyol and a mixture thereof, water and a buffer system that provides a buffered pH value for the composition in the range of about 3 to about 7.4 is administered to the penile meatus.

  提供了治疗早泄的组合物和方法，其中包括一种含有局部麻醉剂、剪切稀释聚合物增稠剂、选择自脂肪族C1到C8醇、脂肪族C8到C30酯、液态多元醇或其混合物的亲脂成分、水和缓冲系统的组合物，该缓冲系统为组合物提供了在约3至约7.4范围内的缓冲pH值，并将其用于阴茎尿道口。
• Short duration depot formulations
  申请人：——

  公开号：US20040001889A1

  公开（公告）日：2004-01-01

  Methods and compositions for systemically or locally administering by implantation a beneficial agent to a subject are described, and include, for example, depot gel compositions that can be injected into a desired location and which can provide controlled release of a beneficial agent over a short duration of time. The compositions include a low molecular weight biocompatible polymer, a biocompatible solvent having low water miscibility that forms a viscous gel with the polymer and limits water uptake by the implant, and a beneficial agent.

  本文描述了系统性或局部通过植入给予有益药物的方法和组合物，其中包括例如可注射到所需位置的储库凝胶组合物，可以在短时间内提供有益药物的控制释放。该组合物包括低分子量生物相容性聚合物、生物相容性溶剂，具有低水溶性，与聚合物形成黏稠的凝胶，并限制植入物的吸水性，以及有益药物。
• SHORT DURATION DEPOT FORMULATIONS
  申请人：Chen Guohua

  公开号：US20060165800A1

  公开（公告）日：2006-07-27

  Methods and compositions for systemically or locally administering by implantation a beneficial agent to a subject are described, and include, for example, depot gel compositions that can be injected into a desired location and which can provide controlled release of a beneficial agent over a short duration of time. The compositions include a low molecular weight biocompatible polymer, a biocompatible solvent having low water miscibility that forms a viscous gel with the polymer and limits water uptake by the implant, and a beneficial agent.

  本文描述了用于系统性或局部通过植入向受体施用有益剂的方法和组合物，其中包括例如可注入到所需位置的蓄积凝胶组合物，其可以在短时间内控制释放有益剂。该组合物包括低分子量生物相容性聚合物、生物相容性溶剂，具有低水亲和性，与聚合物形成粘稠凝胶，并限制了植入物的吸水，以及有益剂。
• Injectable multimodal polymer depot compositions and uses thereof
  申请人：——

  公开号：US20040022859A1

  公开（公告）日：2004-02-05

  Injectable depot compositions are provided that include a polymer matrix having a plurality of bioerodible, biocompatible polymers wherein wherein each polymer of the plurality of polymers has a specified weight average molecular weight; and the polymer matrix has a broad molecular weight distribution of the plurality of polymers; a solvent having a miscibility in water of less than or equal to 7 wt. % at 25° C., in an amount effective to plasticize the polymer and form a gel therewith; and a beneficial agent. The compositions are have substantially improved the shear thinning behavior and reduced injection force, rendering the compositions readily implanted beneath a patient's body surface by injection.

  提供可注射的缓释剂组合物，其包括具有多种可生物降解、生物相容性聚合物的聚合物基质，其中多种聚合物中的每一种聚合物具有规定的重均分子量；并且聚合物基质具有多种聚合物的宽分子量分布；一种具有在25℃下水中溶解度小于或等于7重量％的溶剂，其数量足以使聚合物增塑并与之形成凝胶；以及一种有益的药剂。这些组合物具有明显改善的剪切变薄行为和减少的注射力，使它们可以通过注射轻松地植入病人身体表面下。